Head Lice

Evolve Your Practice with Spinosad Topical Suspension 0.9%.

Today, every practice needs a solution that effectively treats resistant head lice, while assisting you with changing protocols and patient demands:

Programmatic diagnostic tools to confirm head lice in remote patients

On-demand tools to help patients access product and drive compliance

Perspectives from scientific experts on the latest head lice clinical data

No known resistance to the active compound, spinosad, in head lice³

Formulary & Pharmacy Finders help you quickly confirm insurance coverage and pharmacies with product availability.

Request a virtual or in-person visit with a ParaPROfessional^™ to answer product and treatment questions, or help with practice tools.

Request a rep visit

Reference(s)

Gellatly KJ, Krim S,Palenchar DJ, et al. Expansion of the knockdown resistance frequency map for human head lice (phthiraptera: pediculidae) in the United States using quantitative sequencing. Journal of Medical Entomology, 2016:1-7.
IQVIA: June 11, 2021.
Spinosad Technical Bulletin Dow AgroSciences LLC (Now Corteva agriscience), Form No. Y45-000-001 (01/01) CBK.
Spinosad Topical Suspension 0.9% Prescribing Information.

SPN-RRW1-002